• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1964年在尼日利亚伊巴丹使用口服疫苗(萨宾株)进行脊髓灰质炎疫苗接种。

Poliomyelitis vaccination in Ibadan, Nigeria, during 1964 with oral vaccine (Sabin strains).

出版信息

Bull World Health Organ. 1966;34(6):865-76.

PMID:5296535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2476045/
Abstract

A mass vaccination campaign of children under 3 years old was carried out in Ibadan in late 1964, following a marked increase in the incidence of paralytic poliomyelitis the previous year. Two doses of Sabin-strain attenuated poliomyelitis vaccine were given-the first of type 2 virus and the second of bivalent vaccine containing type 1 and type 3 viruses-with an interval of four weeks between doses. Although serological tests indicated a low antibody response, there was a pronounced and sustained fall in the incidence of the disease.It is concluded that the immunization schedules currently recommended in North America and Europe (namely, three doses at intervals of 4-8 weeks) are not suitable in Ibadan and similar cities in other parts of Africa, where the type of schedule used in this study is preferable. The virtual elimination of the disease from such regions is not at present a practical proposition, but the annual repetition of mass vaccination campaigns should prevent any increases in its incidence.

摘要

1964年末,在伊巴丹开展了针对3岁以下儿童的大规模疫苗接种活动,此前一年麻痹性脊髓灰质炎发病率显著上升。接种了两剂萨宾株减毒脊髓灰质炎疫苗,第一剂为2型病毒疫苗,第二剂为含1型和3型病毒的二价疫苗,两剂之间间隔四周。尽管血清学检测显示抗体反应较低,但该病的发病率出现了明显且持续的下降。得出的结论是,北美和欧洲目前推荐的免疫接种方案(即每隔4 - 8周接种三剂)在伊巴丹及非洲其他地区的类似城市并不适用,在这些地区本研究中使用的接种方案更为可取。目前在这些地区实际上无法消除该疾病,但每年重复开展大规模疫苗接种活动应能防止其发病率上升。

相似文献

1
Poliomyelitis vaccination in Ibadan, Nigeria, during 1964 with oral vaccine (Sabin strains).1964年在尼日利亚伊巴丹使用口服疫苗(萨宾株)进行脊髓灰质炎疫苗接种。
Bull World Health Organ. 1966;34(6):865-76.
2
Effectiveness of immunization against paralytic poliomyelitis in Nigeria.尼日利亚脊髓灰质炎疫苗对预防麻痹型脊髓灰质炎的有效性。
N Engl J Med. 2008 Oct 16;359(16):1666-74. doi: 10.1056/NEJMoa0803259.
3
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.用于预防脊髓灰质炎的序贯灭活脊髓灰质炎疫苗(IPV)和口服脊髓灰质炎减毒活疫苗(OPV)
Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2.
4
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.现场萨宾疫苗的返祖现象:尼日利亚类似萨宾株脊髓灰质炎病毒分离株的综合分析
J Virol. 2015 Oct 14;90(1):317-31. doi: 10.1128/JVI.01532-15. Print 2016 Jan 1.
5
Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trial.中国浙江三种序贯接种程序使用沙宾灭活脊髓灰质炎疫苗和二价口服脊髓灰质炎疫苗的免疫原性:一项开放标签、随机、对照试验
Lancet Infect Dis. 2020 Sep;20(9):1071-1079. doi: 10.1016/S1473-3099(19)30738-8. Epub 2020 May 19.
6
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防:采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.
7
Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.通过比较中国不同脊髓灰质炎疫苗接种程序评估1型和3型口服脊髓灰质炎二价疫苗的免疫原性和安全性:一项随机对照非劣效性临床试验
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-10. doi: 10.1080/21645515.2017.1288769. Epub 2017 Mar 1.
8
Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.马达加斯加根除脊髓灰质炎的大规模疫苗接种运动:口服脊髓灰质炎疫苗提高了错过常规计划儿童的免疫力。
Trop Med Int Health. 2001 Dec;6(12):1032-9. doi: 10.1046/j.1365-3156.2001.00812.x.
9
Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.在大规模疫苗接种运动与常规免疫规划中口服脊髓灰质炎疫苗的免疫原性。
Bull World Health Organ. 1995;73(6):769-77.
10
Prospects for the eradication of infectious diseases.根除传染病的前景。
Rev Infect Dis. 1984 May-Jun;6(3):405-11. doi: 10.1093/clinids/6.3.405.

引用本文的文献

1
The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.腹泻病对尼泊尔婴儿二价口服脊髓灰质炎疫苗(bOPV)免疫反应的影响。
Vaccine. 2016 May 11;34(22):2519-26. doi: 10.1016/j.vaccine.2016.03.027. Epub 2016 Apr 13.
2
Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.在冈比亚婴儿中,爱泼斯坦-巴尔病毒而非巨细胞病毒与疫苗抗体反应降低有关。
PLoS One. 2010 Nov 17;5(11):e14013. doi: 10.1371/journal.pone.0014013.
3
Sero-conversion after oral polio vaccine.
Indian J Pediatr. 1978 Oct;45(369):310-3. doi: 10.1007/BF02749258.

本文引用的文献

1
Oral poliovirus vaccine. Recent results and recommendations for optimum use.
R Soc Health J. 1962 Mar-Apr;82:51-9. doi: 10.1177/146642406208200205.
2
Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses.口服脊髓灰质炎活疫苗。在其他病毒引起大规模肠道感染的情况下,快速大规模免疫对人群的影响。
JAMA. 1960 Aug 6;173:1521-6. doi: 10.1001/jama.1960.03020320001001.
3
COMMENTARY ON REPORT ON ORAL POLIOMYELITIS VACCINES.关于口服脊髓灰质炎疫苗报告的评论
JAMA. 1964 Oct 5;190:52-5. doi: 10.1001/jama.1964.03070140058008.
4
MASS IMMUNIZATION OF CHILDREN WITH ORAL, TRIVALENT POLIOVIRUS VACCINE (LEDERLE STRAINS).用口服三价脊髓灰质炎病毒疫苗(礼来株)对儿童进行大规模免疫接种。
Pediatrics. 1964 Jun;33:878-86.
5
PREVENTION OF POLIOMYELITIS IN SINGAPORE BY LIVE VACCINE.用活疫苗预防新加坡的小儿麻痹症
Br Med J. 1964 Apr 25;1(5390):1077-80. doi: 10.1136/bmj.1.5390.1077.
6
Poliomyelitis in Nigeria.尼日利亚的脊髓灰质炎
West Afr Med J. 1961 Aug;10:217-22.